Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term home parenteral nutrition with Lipidem versus Lipofundin MCT
2005-001938-32Phase 4Completed
- Sponsor
- B. Braun
- Start
- Apr 2007
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Lipidem and medium-chain triglycerides + long-chain triglycerides in intestinal failure (IF), intestinal malabsorption and deficiency disorders (2 arms), sponsored by B. Braun. Primary endpoint: Body mass index noninferiority. Started Apr 2007; status: completed.
02
Drugs
Lipidemmedium-chain triglycerides + long-chain triglycerides
03
Conditions
intestinal failure (IF)intestinal malabsorptiondeficiency disorders
Beyond the preview
Go deeper on 2005-001938-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001938-32.